223 related articles for article (PubMed ID: 19747978)
1. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan.
Oliveira DL; Nimrichter L; Miranda K; Frases S; Faull KF; Casadevall A; Rodrigues ML
Fungal Genet Biol; 2009 Dec; 46(12):956-63. PubMed ID: 19747978
[TBL] [Abstract][Full Text] [Related]
2. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
[TBL] [Abstract][Full Text] [Related]
3. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.
Rodrigues ML; Nimrichter L; Oliveira DL; Frases S; Miranda K; Zaragoza O; Alvarez M; Nakouzi A; Feldmesser M; Casadevall A
Eukaryot Cell; 2007 Jan; 6(1):48-59. PubMed ID: 17114598
[TBL] [Abstract][Full Text] [Related]
4. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.
García-Rivera J; Chang YC; Kwon-Chung KJ; Casadevall A
Eukaryot Cell; 2004 Apr; 3(2):385-92. PubMed ID: 15075268
[TBL] [Abstract][Full Text] [Related]
6. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
Cleare W; Casadevall A
Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
[TBL] [Abstract][Full Text] [Related]
7. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
[TBL] [Abstract][Full Text] [Related]
8. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
McFadden DC; De Jesus M; Casadevall A
J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
[TBL] [Abstract][Full Text] [Related]
9. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.
Ramos CL; Fonseca FL; Rodrigues J; Guimarães AJ; Cinelli LP; Miranda K; Nimrichter L; Casadevall A; Travassos LR; Rodrigues ML
Eukaryot Cell; 2012 Sep; 11(9):1086-94. PubMed ID: 22562469
[TBL] [Abstract][Full Text] [Related]
10. The Overlooked Glycan Components of the Cryptococcus Capsule.
Fonseca FL; Reis FCG; Sena BAG; Jozefowicz LJ; Kmetzsch L; Rodrigues ML
Curr Top Microbiol Immunol; 2019; 422():31-43. PubMed ID: 30203395
[TBL] [Abstract][Full Text] [Related]
11. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML
Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547
[TBL] [Abstract][Full Text] [Related]
12. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
13. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.
Jesus MD; Nicola AM; Chow SK; Lee IR; Nong S; Specht CA; Levitz SM; Casadevall A
Virulence; 2010; 1(6):500-8. PubMed ID: 21178496
[TBL] [Abstract][Full Text] [Related]
14. Exploring
Crawford CJ; Cordero RJB; Guazzelli L; Wear MP; Bowen A; Oscarson S; Casadevall A
J Biol Chem; 2020 Mar; 295(13):4327-4340. PubMed ID: 32005661
[TBL] [Abstract][Full Text] [Related]
15.
Kuttel MM; Casadevall A; Oscarson S
Molecules; 2020 Jun; 25(11):. PubMed ID: 32517333
[TBL] [Abstract][Full Text] [Related]
16.
Gonçalves DS; Rodriguez de La Noval C; Ferreira MDS; Honorato L; Araújo GRS; Frases S; Pizzini CV; Nosanchuk JD; Cordero RJB; Rodrigues ML; Peralta JM; Nimrichter L; Guimarães AJ
Front Cell Infect Microbiol; 2020; 10():565571. PubMed ID: 33585262
[TBL] [Abstract][Full Text] [Related]
17. Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.
Todaro-Luck F; White EH; Reiss E; Cherniak R
Mol Cell Probes; 1989 Dec; 3(4):345-61. PubMed ID: 2482437
[TBL] [Abstract][Full Text] [Related]
18. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil.
Dal Pupo HD; Sena BAG; Reis FCG; Machado L; Fortes ST; de Almeida Junior JN; Godinho RMC; Rodrigues ML
Fungal Biol; 2019 Oct; 123(10):699-708. PubMed ID: 31542188
[TBL] [Abstract][Full Text] [Related]
20. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.
Fonseca FL; Nimrichter L; Cordero RJ; Frases S; Rodrigues J; Goldman DL; Andruszkiewicz R; Milewski S; Travassos LR; Casadevall A; Rodrigues ML
Eukaryot Cell; 2009 Oct; 8(10):1543-53. PubMed ID: 19617395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]